![Thomas Bures](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Bures
Comptroller/Controller/Auditor bij
BRUKER CORPORATION
Vermogen: 188 330 $ op 31-05-2026
Profiel
Thomas Bures is Chief Accounting Officer at Bruker Corp.
since 2025.
Formerly, Mr. Bures was Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. from 2021 to 2024, Vice President & Controller at Genocea Biosciences, Inc. from 2015 to 2017, Vice President & Assistant Controller at PAREXEL International Corp., and Chief Financial Officer at Palvella Therapeutics, Inc. Education includes an undergraduate degree from College of the Holy Cross (Massachusetts).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-02-2026 | 3.198 ( 0% ) | 188 330 $ | 31-05-2026 |
Actieve functies van Thomas Bures
| Bedrijven | Functie | Begin |
|---|---|---|
| BRUKER CORPORATION | Comptroller/Controller/Auditor | 13-01-2025 |
Eerdere bekende functies van Thomas Bures
| Bedrijven | Functie | Einde |
|---|---|---|
| PIERIS PHARMACEUTICALS | Financieel Directeur/CFO | 13-12-2024 |
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01-12-2017 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Opleiding van Thomas Bures
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
